RedHill Biopharma raises ATM capacity to $2.59 million under Form F-3 limitOct 13FinancingRedHill Biopharma Ltd.
RedHill reports H1 2026 results after Rebyota, Clenpiq deal and Talicia exitSep 30Quarterly updateomeprazole magnesium, amoxicillin and rifabutinRedHill Biopharma Ltd.
RedHill details Rebyota, Clenpiq deal terms and market data for Ferring GI drugsSep 1M&ARedHill Biopharma Ltd.
RedHill Biopharma expands at-the-market offering capacity by $2.128 millionJun 29FinancingRedHill Biopharma Ltd.